Babiators launches new children’s Rx line

Article

Babiators recently announced the launch of Babiators Rx, a new line of prescription spectacles for kids.

Atlanta-Babiators recently announced the launch of Babiators Rx, a new line of prescription spectacles for kids. Babiators Rx will provide children with flexible and fashionable frames to help them see the world a bit more clearly and come equipped with Babiators’ “Lost & Found” guarantee, which ensures that the company will replace any lost or broken frames within one year of purchase.

Maximizing sunglasses sales

Composed of malleable, lightweight TR-90 nylon material, the Babiators Rx specs are built to withstand the active lifestyles of energetic young kids. Soft rubber molding around the eyes and nose promises a cozy, comfortable fit, and each pair of Babiators Rx includes an extra set of temples that have a comfort fit around the ear to keep the glasses firmly on younger, more active kids. Babiators has crafted two different frame designs to best suit boys’ and girls’ distinctive face shapes. The “Buzz” frame sports a modern rectangular design with a cool hipster feel, while the “Sally” frame’s cat-eye silhouette generates a classic, retro vibe. Both frames come with a case and lens cloth.

The Buzz and Sally frames are each available in three vibrant shades. The Buzz frame is offered in the Princess Pink, Blue Angels Blue, and Galactic Gray colors, while the Sally frame comes in Popstar Pink, Blue Angels Blue, and Galactic Gray. Babiators Rx are made for children ages two and above and retail for $110. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.